| December 15, 2023 | | | By: Future Health ESG Corp. | |
| | | |
/s/ Bradley A. Bostic
Bradley A. Bostic
Chief Executive Officer |
|
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 12 | | | |
| | | | | 17 | | | |
| | | | | 17 | | | |
| | | | | 17 | | | |
| | | | | 17 | | | |
| | | | | 17 | | | |
| | | | | 18 | | | |
| | | | | 18 | | | |
| | | | | 18 | | | |
| | | | | 19 | | | |
| | | | | 19 | | | |
| | | | | 19 | | | |
| | | | | 19 | | | |
| | | | | 20 | | | |
| | | | | 21 | | | |
| | | | | 22 | | | |
| | | | | 22 | | | |
| | | | | 22 | | | |
| | | | | 23 | | | |
| | | | | 23 | | | |
| | | | | 24 | | | |
| | | | | 25 | | | |
| | | | | 30 | | | |
| | | | | 31 | | | |
| | | | | 32 | | | |
| | | | | 33 | | | |
| | | | | 34 | | | |
| | | | | 34 | | | |
| | | | | A-1 | | | |
| | | | | B-1 | | |
| | |
Number of
Shares of Future Health |
| |||||||||
Name and Address of Beneficial Owner(1)
|
| |
Common Stock
|
| |
%(2)
|
| ||||||
Directors and Executive Officers of Future Health: | | | | | | | | | | | | | |
Bradley A. Bostic(3)
|
| | | | 3,247,076 | | | | | | 49.3% | | |
Travis A. Morgan(3)
|
| | | | 3,134,577 | | | | | | 47.6% | | |
R. Mark Lubbers
|
| | | | 11,250 | | | | | | * | | |
Dr. F. John Mills
|
| | | | 11,250 | | | | | | * | | |
Dr. Nancy L. Snyderman
|
| | | | 11,250 | | | | | | * | | |
All Directors and Executive Officers of Future Health as a Group (5 Individuals)
|
| | | | 3,770,201 | | | | | | 57.2% | | |
Five Percent Holders of Future Health: | | | | | | | | | | | | | |
Future Health ESG Associates 1, LLC(3)
|
| | | | 2,625,000 | | | | | | 39.8% | | |
BEA Holdings LLC
|
| | | | 489,375 | | | | | | 7.4% | | |
M2 Enterprises Holdings LLC
|
| | | | 489,375 | | | | | | 7.4% | | |
| | | |
FOR
|
| |
AGAINST
|
| |
ABSTAIN
|
|
| Proposal 1 – Extension Amendment Proposal | | | | | | | | | | |
| Amend the Company’s Amended and Restated Certificate of Incorporation, giving the Company the right to extend the date by which it has to consummate a business combination from December 31, 2023 to December 31, 2024. | | |
☐
|
| |
☐
|
| |
☐
|
|
| | | |
FOR
|
| |
AGAINST
|
| |
ABSTAIN
|
|
| Proposal 2 – Adjournment Proposal | | | | | | | | | | |
| To adjourn the special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the special meeting, there are insufficient shares of outstanding capital stock of the Company represented (either in person or by proxy) to constitute a quorum necessary to conduct business at the special meeting or at the time of the special meeting to approve the Extension Amendment Proposal. | | |
☐
|
| |
☐
|
| |
☐
|
|